中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
18期
103-104
,共2页
慢性荨麻疹%胸腺五肽%抗组胺药
慢性蕁痳疹%胸腺五肽%抗組胺藥
만성담마진%흉선오태%항조알약
Chronic urticaria%Thymopoietin-5%Antihistamine
目的:探讨胸腺五肽联合抗组胺药治疗慢性荨麻疹(CU)的效果。方法:根据患者自愿,将150例患者分为观察组(95例)和对照组(55例)。两组在抗组胺药治疗的基础上,对照组隔日注射胸腺五肽2 mg,观察组每日注射胸腺五肽10 mg。比较两组疗效、不良反应发生率和复发率。结果:观察组治疗有效率为93.7%,显著高于对照组(x2=11.716,P<0.05)。观察不良反应发生率为7.4%,与对照组无统计学差异(x2=0.907,P>0.05)。观察组复发率为17.4%,显著低于对照组(x2=8.454,P<0.05)。结论:在抗组胺药的基础上,每日持续使用胸腺五肽治疗慢性荨麻疹可以获得更好的疗效,降低复发率,值得临床推广运用。
目的:探討胸腺五肽聯閤抗組胺藥治療慢性蕁痳疹(CU)的效果。方法:根據患者自願,將150例患者分為觀察組(95例)和對照組(55例)。兩組在抗組胺藥治療的基礎上,對照組隔日註射胸腺五肽2 mg,觀察組每日註射胸腺五肽10 mg。比較兩組療效、不良反應髮生率和複髮率。結果:觀察組治療有效率為93.7%,顯著高于對照組(x2=11.716,P<0.05)。觀察不良反應髮生率為7.4%,與對照組無統計學差異(x2=0.907,P>0.05)。觀察組複髮率為17.4%,顯著低于對照組(x2=8.454,P<0.05)。結論:在抗組胺藥的基礎上,每日持續使用胸腺五肽治療慢性蕁痳疹可以穫得更好的療效,降低複髮率,值得臨床推廣運用。
목적:탐토흉선오태연합항조알약치료만성담마진(CU)적효과。방법:근거환자자원,장150례환자분위관찰조(95례)화대조조(55례)。량조재항조알약치료적기출상,대조조격일주사흉선오태2 mg,관찰조매일주사흉선오태10 mg。비교량조료효、불량반응발생솔화복발솔。결과:관찰조치료유효솔위93.7%,현저고우대조조(x2=11.716,P<0.05)。관찰불량반응발생솔위7.4%,여대조조무통계학차이(x2=0.907,P>0.05)。관찰조복발솔위17.4%,현저저우대조조(x2=8.454,P<0.05)。결론:재항조알약적기출상,매일지속사용흉선오태치료만성담마진가이획득경호적료효,강저복발솔,치득림상추엄운용。
Objective:To investigate efficacy of thymopoietin-5 plus antihistamines on chronic urticaria.Methods:150 patients were divided into obs ervation group ( 95 c ases) a nd control group (55 cases).With antihistamines in both groups;the c ontrol group w as injected 2mg thymopoietin-5 e very 2 days while the obs ervation group w as injected 10mg thymopoietin-5 every da y.Results:The e fficacy in the observation group was 93.7%,significantly higher than thatin control group(x2=11.716,P<0.05).The adverse reaction rate in the observation was 7. 4%,with no s ignificantdi fference ( x2=0.907, P>0.05). The re currence rate of obs ervation group w as 17. 39%, significantly l ower (x2=8.454, P<0.05). Conclusion:With antihistamine before, continuous application of thymopoietin-5 can obtain better efficacy for chronic urticaria and less adverse reaction, which is worthy of clinical promotion.